Osmind Blog

Research
Osmind News
Private Practice
Podcast
Breakthrough Treatments

Transforming MDD Symptom Management with a Digital Therapeutic

Discover Rejoyn®, the first FDA-authorized prescription digital treatment as an adjunct to ADT for adult patients with MDD. This smartphone-delivered intervention offers psychiatrists a different approach to offer their appropriate patients that can help treat MDD symptoms. The intended audience for this program is healthcare professionals involved in the treatment of patients with MDD. See the Clinician Brief Summary at rejoynhcp.com
Osmind

New

Breakthrough Treatments

Transforming MDD Symptom Management with a Digital Therapeutic

Osmind News

The Rules of Psychiatry Are Being Rewritten: Welcome to the Osmind Psychiatry Collective

Private Practice

How to Choose the Right Psychiatric Billing Service for Your Practice

Private Practice

The Clinical Entrepreneur: Building a Psychiatric Practice on Your Terms

Osmind News

Osmind Welcomes Dr. Brittany Albright, MD, MPH, as a Medical Advisor

The Rules of Psychiatry Are Being Rewritten: Welcome to the Osmind Psychiatry Collective

How to Choose the Right Psychiatric Billing Service for Your Practice

The Clinical Entrepreneur: Building a Psychiatric Practice on Your Terms

Osmind Welcomes Dr. Brittany Albright, MD, MPH, as a Medical Advisor

Clozapine REMS Program Ends: What Psychiatrists Need to Know

From Crisis to Community: Transforming High-Risk Psychiatric Care Beyond Hospital Walls with Matthew Bernstein, MD

Implementing TMS for Adolescent Depression: A Practical Guide for Psychiatric Providers

The Ketamine Breakthrough: A Pioneer's 10 Year Reflection

From Frontier to Framework: ASKP3's New Standards for Ketamine Therapy

‍Osmind Appoints Dr. William Sauvé as Chief Medical Officer to Advance Interventional Psychiatric Care

How the APA’s Transdiagnostic Measure is Getting the Attention it Deserves

Ketamine Therapy Shows Promise for Treatment-Resistant Patients with Comorbid PTSD and MDD

Osmind and UBC partner to Advance Mental Health Treatment Through REMS Innovation

The SPRAVATO® Story: A Paradigm Shift in Depression Treatment

Cobenfy™: A New Approach to Schizophrenia Treatment After 70 Years

A Clinician's Guide to Launching an Innovative Treatment Center

Osmind Increases Access to Breakthrough Mental Health Treatments through Partnerships with Enthea and First Tracks Health

How to Talk with Patients about Measurement-Based Care (MBC): A Practical Guide for Mental Health Clinicians

Debunking Myths About Measurement-Based Care in Psychiatric Practice: A Psychiatrist's Perspective

What to Do After Administering the DSM-5-TR Level 1 Cross-Cutting Symptom Measure (DSM-XC)

Modern Solutions, Better Outcomes: A Psychiatrist's Guide to IV Ketamine

Osmind Welcomes Dr. Robert M. Berman, M.D. as Strategic Advisor

Expecting Better: Expert Perspectives on MDMA-AT’s FDA Journey

Entering Psychiatry's Golden Era with Dr. David Feifel, MD, PhD

Osmind Welcomes Dr. Husseini K. Manji, M.D., F.R.C.P.C., as a Strategic Advisor

WHODAS 2.0 Guide and Score Calculator

GAD-7 Guide and Score Calculator

PHQ-9 Guide and Score Calculator

Metabolic Psychiatry: Can Ketones Transform Mental Health Treatment?

How to Get Started with Measurement-Based Care

New Real-World Evidence Supports Esketamine Nasal Spray as an Effective Treatment for Treatment-Resistant Depression

Comparative Effects of Esketamine and IV Ketamine for Major Depression: A Real-World Analysis

Navigating Adult ADHD and the Stimulant Shortage with Jake Behrens, MD

How to Use the DSM-5-TR Level 1 Cross-Cutting Symptom Measure (DSM-XC)

10 Reasons to Start Using the DSM-5-TR Level 1 Cross-Cutting Measure

Osmind Announces Collaboration with the American Psychiatric Association

APA 2024 Annual Meeting: Sessions to Attend

Moving Interventional Psychiatry Forward: Dr. Rebecca Allen's Insights on Building a Thriving Multimodal Practice

Navigating Finance in Private Practice: Fundamentals and Tax Strategies for Mental Health Clinicians

Evaluating TMS vs ECT vs Ketamine vs Esketamine

Streamline IV Ketamine Screening and Intake Documentation: A Guide for Clinicians

Safeguard Your Ketamine Clinic: Legal Expertise You Need to Know

2024 Community Advisory Board: Clinicians and Thought Leaders Shaping The Future of Mental Health

Embracing Pragmatism for Ketamine Insurance Coverage: Leveraging Real-World Evidence

Letter From a Former Luminello and SimplePractice User (and Why I Switched to Osmind)

Data Without Distraction: Revolutionizing Vitals Monitoring During Ketamine Treatment

Autism, Ketamine, and Restorative Justice with Bergina Isbell, MD

Are You Ready for 2024’s CPT Code Changes for Psychiatrists and Mental Health Professionals?

Harnessing the Power of Microdosing and Wearables: Unveiling the Psynautics Clinical Neuroscience Study

Top 5 EHR Features for Evolving Psychedelic Practices

Clinical Trials and Breakthrough Treatments with Michael Banov, MD

Osmind 2023 Year in Review: A Breakthrough Year for Mental Health Care

Beyond Solo Practice: Thriving through Networking and Community in Private Psychiatry

How to Thrive in Private Psychiatry Practice: Overcoming Challenges and Embracing Change

Can We Predict Ketamine Therapy Outcomes for Depression? This Model May Hold Promise

Community Spotlight: Propel Therapeutics, Defining High-Quality Ketamine Therapy

7 Predictions on Psychiatry's Future: Experts Weigh In

Insurance Credentialing Guide for Mental Health Clinicians

Revolutionizing PTSD Treatment: The Vision of General Stephen Xenakis, M.D.

Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

Stella’s Acquisition of Field Trip Health: A Pivotal Moment in Psychiatry

Osmind Reviews Are In for the Best Mental Health EHR

How to Write IV Ketamine Administration Notes (Template + Guide)

Osmind Recognized as Quarterfinalist in the 2023 Digital Health Awards

How to Write Psychiatry Progress Notes (Template + Examples)

Navigating Ethical Frontiers in Psychiatry: A Conversation with Rebecca Brendel, MD, JD, Immediate Past President of the APA

Shaping the Future of Psychedelic Treatments: Osmind's Response to FDA's Draft Guidance

How to Write Psychiatry Mental Status Exams (MSE)—Template with examples

Scaling innovative treatments: Dr. Tobias Marton's Journey from Psychiatry to Neuroscience to CMO of Mindful Health Solutions

Psychedelic Legal Frontiers: Preparing Practices for MDMA and Beyond with Husch Blackwell

Surprising Insights from Psychedelic Science 2023: Gul Dolen, Elias Dakwar, Michael Bogenschutz, and Karen Luong: Duration of experience, Psilocybin for Substance Abuse, and Legal Challenges

Osmind Announces Publication of Largest Real-World Study on Effectiveness of Ketamine Intravenous Therapy for Depression, Anxiety and Suicidal Ideation

Psychedelic Science 2023: Recommended Sessions to Attend

Tune Into Psychiatry's Next Frontier: Introducing the Psychiatry Tomorrow Podcast

APA 2023 Annual Meeting: Sessions to Attend

Unveiling the Future of TMS: Highlights from the Clinical TMS Society Annual Meeting

Set, Setting, and Unleashing the Healing Potential of Psychedelics with Andrew Penn, MS, PMHNP

How a CPT® Code Becomes “Real”: Implications for the New Psychedelic Medicine CPT® Codes

Transforming Mental Health in Unlikely Places: Denovo Therapy's Approach to Breaking Barriers and the Power of Journaling

The Comprehensive Guide to Integrating SPRAVATO® in Your Practice

Osmind in the News: Innovations in Mental Healthcare and the Promise of Public Benefit Corporations

Navigating the Landscape of Critical Psychiatry: A Conversation with Dr. Awais Aftab

Boldly Go Where No Psychiatrist Has Gone Before with AI and Chat GPT

Safeguarding Mental Health Telepractice: A Call to Action on the DEA's Proposed Rule Changes

Bridging the Gap Between Research and Practice: Insights from Osmind's Research Interest Survey

The Private Psychiatrist's Toolkit: Podcasts, Conferences, Newsletters, and Learning Communities to Elevate Your Practice

Community Spotlight: Dr. Raghu Appasani, MD, Integrative Psychiatrist

Great Expectations: How do we know if psychedelics work? A deep-dive with Dr. Boris Heifets

Announcing the Community Advisory Board (CAB): Movers and Shakers of Psychiatry

Psychopharmacology of Psychedelics: What Every Psychiatrist Needs to Tell Their Patients on SSRIs with Dr. Kelan Thomas

How to Choose the Best EHR for your Psychiatry Practice (Ask THESE 5 questions)

Measurement-Based Care: How to Improve Clinical Outcomes in Mental Health

Community Spotlight: Sonia Cotto of Ketamine and Wellness Clinic of South Florida

Top Mental Health Rating Scales to Make Measurement-Based Care Easy

Grow your Psychiatry Private Practice: A Guide to Reputation Management, Google Business Profile, Directory Listing and Review Sites

12 Psychiatry Note Templates that Cut Your Documentation Time in Half

New Year's Checklist for Outpatient Psychiatrists: 10 Must-Dos for a Productive 2024

2023 Psychiatry CPT® Coding Changes You Need to Know

Establish Your Psychiatry Private Practice Online: What to Put on Your Website

ACNP 2022 highlight: The Role of KORs in Mediating Stress-Related Deficits in Reward Processing: MOA of Ketamine and Aticaprant

logo

Insights

AboutCareersCommunityPodcastBlog

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2025 All Rights Reserved.

Privacy Policy

Terms of Service